Finceramica

Finceramica develops and markets innovative biomimetic bioceramic solutions primarily used in regenerative surgery. Its flagship product line includes patient-specific hydroxyapatite cranial implants ("CustomizedBone Service"), which are FDA-cleared and widely used across Europe and the US. These implants mimic natural bone structure to promote osteointegration with low infection rates. The company also offers advanced solutions for orthopedic, spinal, neurosurgical, and maxillofacial applications using proprietary ceramic technologies. It has a strong record of international certifications (ISO9001/13485), strategic partnerships with companies like Kelyniam Global in the US market, ongoing collaborations with research institutes, over three decades of innovation since its founding as a spin-off from ISTEC-CNR, and operates as part of the Tampieri Group.